AstraZeneca COVID-19 vaccine can be 90% effective, results show

Published On: November 23, 2020 01:17 PM NPT By: Reuters

LONDON, Nov 23:  AstraZeneca said on Monday its vaccine for the novel coronavirus, developed along with the University of Oxford, could be around 90% effective under one dosing regimen.

Moderna to charge $25-$37 for COVID-19 vaccine: CEO tells paper

Published On: November 22, 2020 01:40 PM NPT By: Reuters

FRANKFURT, Nov 22: Moderna will charge governments between $25 and $37 per dose of its COVID-19 vaccine candidate, depending on the amount ordered, Chief Executive Stephane Bancel told German weekly Welt am Sonntag (WamS).

WHO suspends remdesivir from list of medicines

Published On: November 21, 2020 12:09 PM NPT By: Reuters

GENEVA, Nov 21: The World Health Organization said on Friday it has suspended Gilead’s remdesivir from its so-called prequalification list, an official list of medicines used as a benchmark for procurement by developing countries, after issuing guidance against its use in hospitalised COVID-19 patients.

Pfizer to submit U.S. emergency use application for COVID-19 vaccine

Published On: November 20, 2020 06:49 PM NPT By: Reuters

NEW YORK, Nov 20: Pfizer Inc said it will apply to U.S. health regulators on Friday for emergency use authorization (EUA) of its COVID-19 vaccine, the first such application in a major step toward providing protection against the new coronavirus.

Oxford scientists expect COVID-19 vaccine data by Christmas

Published On: November 19, 2020 07:35 PM NPT By: Associated Press

LONDON, Nov 19:  University of Oxford scientists expect to report results from the late-stage trials of their COVID-19 vaccine by Christmas, a key researcher said Thursday as he discussed the team’s latest findings.

Moderna says its vaccine is 94.5% effective in preventing COVID-19

Published On: November 17, 2020 08:30 AM NPT By: Reuters

MASSACHUSETTS, Nov 17: Moderna Inc’s experimental vaccine was 94.5% effective in preventing COVID-19 based on interim data from a late-stage trial, the company said on Monday, becoming the second U.S. drugmaker to report results that far exceed expectations.

SAN FRANCISCO, Oct 15: Facebook and Twitter cast doubt on a New York Post story that made claims about Democratic presidential candidate Joe Biden’s son, taking proactive steps to restrict dissemination of the story in the hours after it was published on Wednesday.

Russia's COVID-19 vaccine showed antibody response in initial trials

Published On: September 5, 2020 12:14 PM NPT By: Reuters

MOSCOW, Sept 5: Russia’s “Sputnik-V” COVID-19 vaccine produced an antibody response in all participants in early-stage trials, according to results published on Friday by The Lancet medical journal that were hailed by Moscow as an answer to its critics.

SAN FRANCISCO, Aug 27: TikTok CEO Kevin Mayer has left the Chinese-owned video app firm just three months since joining, and only days since the company sued the administration of U.S. President Donald Trump over an executive order effectively banning it in the United States.

BEIJING/SHANGHAI, Aug 3: Microsoft Corp said it will push ahead with talks to acquire the U.S. operations of Chinese-owned short-video app TikTok, a potential blockbuster deal that could re-shape the social media industry and further inflame crumbling U.S.-China relations.